# Frontida BioPharm Inc - Inspection Records

Source: https://www.globalkeysolutions.net/companies/frontida-biopharm-inc/dc8190f9-0e13-4160-a611-dcf664f43b09

> Inspection records and compliance data for Frontida BioPharm Inc in Philadelphia, Pennsylvania. Access full analysis and detailed observations.

---

## Details

- Name: Frontida BioPharm Inc
- FEI Number: 2523348
- City: Philadelphia
- State: Pennsylvania
- Country Name: United States
- Address Line 1: 1100 Orthodox St
- Zip Code: 19124
- Business Operations: API/FDF ANALYTICAL TESTING, FDF MANUFACTURE, PACK

## Related Documents

- [FDA Inspection 1279864 - Frontida BioPharm Inc - 2025-07-22](https://www.globalkeysolutions.net/records/fda_inspections/frontida-biopharm-inc/3101339c-fce2-4e3e-a252-bba7278ebab9) — source: FDA, date: July 22, 2025
- [FDA Inspection 1280570 - Frontida BioPharm Inc - 2025-07-22](https://www.globalkeysolutions.net/records/fda_inspections/frontida-biopharm-inc/e9e3ea78-a2cf-4076-a032-699c41a29a7d) — classification: No Action Indicated (NAI), source: FDA, date: July 22, 2025
- [FDA Inspection 1279864 - Frontida BioPharm Inc - 2025-07-22](https://www.globalkeysolutions.net/records/fda_inspections/frontida-biopharm-inc/be6ada2f-716c-4ddd-8b36-f7d3b7cd65b3) — classification: No Action Indicated (NAI), source: FDA, date: July 22, 2025
- [483 - Frontida BioPharm Inc - 2023-12-07](https://www.globalkeysolutions.net/records/483/frontida-biopharm-inc/c91263e1-f4e2-4769-aada-9f498f973d1f) — source: FDA, date: December 7, 2023
- [FDA Inspection 1226606 - Frontida BioPharm Inc - 2023-12-07](https://www.globalkeysolutions.net/records/fda_inspections/frontida-biopharm-inc/9b8055f0-3548-413c-a40b-5814226a9434) — classification: Voluntary Action Indicated (VAI), source: FDA, date: December 7, 2023
- [FDA Inspection 1097023 - Frontida BioPharm Inc - 2019-07-19](https://www.globalkeysolutions.net/records/fda_inspections/frontida-biopharm-inc/19fa9164-4fb0-41e4-9013-e9731116e4ad) — classification: Voluntary Action Indicated (VAI), source: FDA, date: July 19, 2019
- [FDA Inspection 1027425 - Frontida BioPharm Inc - 2017-07-20](https://www.globalkeysolutions.net/records/fda_inspections/frontida-biopharm-inc/aad2504d-82c1-4c34-88ba-abef0ce49d99) — classification: No Action Indicated (NAI), source: FDA, date: July 20, 2017
- [FDA Inspection 1007832 - Frontida BioPharm Inc - 2017-03-31](https://www.globalkeysolutions.net/records/fda_inspections/frontida-biopharm-inc/ecd75cf3-3eb9-47eb-a2f2-38adbdb18510) — classification: Voluntary Action Indicated (VAI), source: FDA, date: March 31, 2017
- [FDA Inspection 936055 - Frontida BioPharm Inc - 2015-07-17](https://www.globalkeysolutions.net/records/fda_inspections/frontida-biopharm-inc/2cf91318-6f6b-4647-a138-7593f304329e) — classification: Official Action Indicated (OAI), source: FDA, date: July 17, 2015
- [FDA Inspection 890268 - Frontida BioPharm Inc - 2014-07-25](https://www.globalkeysolutions.net/records/fda_inspections/frontida-biopharm-inc/a9d9ad5f-5d6a-496e-9e9b-81eafb784920) — classification: Voluntary Action Indicated (VAI), source: FDA, date: July 25, 2014
- [FDA Inspection 798486 - Frontida BioPharm Inc - 2012-09-13](https://www.globalkeysolutions.net/records/fda_inspections/frontida-biopharm-inc/e6f21b8a-fa56-48fe-bf78-4c7e1041899d) — classification: No Action Indicated (NAI), source: FDA, date: September 13, 2012

## Related Companies

- [LGM Pharma Solutions, LLC](https://www.globalkeysolutions.net/companies/lgm-pharma-solutions-llc/5ee22c42-8e6e-4af9-a2b7-832e0d586f19)
- [L. Perrigo Company](https://www.globalkeysolutions.net/companies/l-perrigo-company/33abbe15-b6ff-4a2b-a8bb-563cb2a55d49)
- [Noxell Corporation](https://www.globalkeysolutions.net/companies/noxell-corporation/0c12f714-89cc-48e4-92fc-1726842646d2)
- [Janssen Pharmaceutica, N.V.](https://www.globalkeysolutions.net/companies/janssen-pharmaceutica-nv/7ed39763-06a4-46b7-a9a1-76399c53844c)
- [Jianerkang Medical Co., Ltd](https://www.globalkeysolutions.net/companies/jianerkang-medical-co-ltd/4cd5cca8-7e53-45e0-9fe5-42981a741cd0)
- [Ferndale Laboratories, Inc.](https://www.globalkeysolutions.net/companies/ferndale-laboratories-inc/0c6013f2-a6e7-41ff-a461-1e3fda056678)
- [Prime Matter Labs](https://www.globalkeysolutions.net/companies/prime-matter-labs/dddd6753-e267-4dbe-af3e-69350e9aab1c)
- [Genzyme Corporation](https://www.globalkeysolutions.net/companies/genzyme-corporation/a58b7a37-69a3-45d1-a590-72294e5e7a17)
- [Nostrum Laboratories Inc](https://www.globalkeysolutions.net/companies/nostrum-laboratories-inc/413bfa94-38e9-443d-a6fd-f3028c7156bf)
- [Ingenus Pharmaceuticals NJ, LLC.](https://www.globalkeysolutions.net/companies/ingenus-pharmaceuticals-nj-llc/542b7622-3ecf-48db-9fc6-0edf6cc42665)

## Related Officers

- [Consumer Safety Officer ](https://www.globalkeysolutions.net/people/anastasia-m-shields/a22b8d52-e3f9-4e61-aa3f-6f03ff2f59df)
